3STATHOPOULOS GP, ANTONIOU D, DIMITROULIS J, et al.Liposomal cis- platin combined with paclitaxel versus cisplatin and paclitaxel in non- small-cell lung cancer: a randomized phase Ⅲ multicanter trial [J]. Ann 0ncol,2010,21(11) : 2227 - 2232.
4BOULIKAS T,MYLONAKIS N,ATHANASIOU A,et al. Liposomally-en- capsulated cisplatin (Lipoplatin) plus gemcitabine in NSCLC: preliminary results of a phase Ⅱ trial and its antiangiogenesis potemial[J].Clin Oncol, 2008,26(15) : 1421 - 1429.
6Ferrandina G,Ludovisi M,Lorusso D,et al.Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer[J].J Clin Oncol,2008.26(6):890-6.
7Sehouli J,Camara O,Schmidt M,et al.Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer:results of a German multicenter observational study[J].Cancer Chemother Pharmacol,2009,64(3):585-91.
8Pignata S,Scambia G,Savarese A,et al.Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer:preliminary activity results of the MITO-2 phase III trial[J].Oncology,2009.76(1):49-54.
9Markman M,Moon J,Wilczynski S,et al.Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer:final survival results of a SWOG (S0200) phase 3 randomized trial[J].Gynecol Oncol,2010.116(3):323-5.
10Kavanagh JJ,Levenback CF,Ramirez PT,et al.Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer[J].J Hematol Oncol,2010.3(1):9.
